BME100 f2013:W1200 Group9 L2

From OpenWetWare

Jump to: navigation, search
BME 100 Fall 2013 Home
People
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Photos
Wiki Editing Help
Image:BME494_Asu_logo.png


Contents

OUR TEAM

Name: Michelle Sigona
Name: Michelle Sigona
Name: Kenna Lum
Name: Kenna Lum
Name: Salvador Avina
Name: Salvador Avina
Name: Rachael Hall
Name: Rachael Hall
Name: Jessica Stradford
Name: Jessica Stradford

LAB 2 WRITE-UP

Descriptive Statistics

Experiment 1 Image:BME100_Group-9_6.jpg Experiment 2 Image:BME100_Group-9_5.jpg

(Please report descriptive statistics for both experiments. Please calculate descriptive statistics in Excel.)




Results

Experiment 1 Image:BME100_Group-9_2.jpg Experiment 2 Image:BME100_Group-9.jpg

(Please include well-labeled graphs of the results.)




Analysis

Experiment 1 Image:BME100_Group-9_4.jpg

Experiment 2 Image:BME100_Group-9_3.jpg

(Using inferential statistics, please determine statistically significant differences in the data.)





Summary/Discussion

After analyzing the data given, we were able to determine various calculations. We were able to calculate averages, t-tests, standard deviation and ANOVA through an excel spreadsheet. The data we analyzed for both humans and rats proved a higher dosage of the protein administered will result in an increase of inflammotin in the body. In rats, the change in the amount of inflammotin did not change much when the dosage increased from 0mg to 10mg. However, in humans, there was a steady increase in inflammotin when increasing the protien from 0mg to 5mg and 5mg to 10mg. When increasing the dosage from 10mg to 15mg in humans, the amount of inflammotin increased greatly. We can conclude that 15mg is the most effective amount of protein that should be given in order to highly increase the amount of inflammotin in the human body.







Personal tools